TP53 status and impact on AML prognosis within the ELN 2022 risk classification. Fleming S, Tsai XC, Morris R, Hou HA, et al. Blood 2023;142:2029-2033.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fleming S, Tsai XC, Morris R, Hou HA, et al. TP53 status and impact on AML prognosis within the ELN 2022 risk classification. Blood 2023;142:2029-2033.
PMID: 37647854